Rezolute, Inc. (NV) Share Price
NASDAQ: RZLT | Small CapRezolute, Inc. (NV) Stock Performance
Open $4.78 | Prev. Close $4.70 | Circuit Range N/A |
Day Range $4.54 - $4.78 | Year Range $1.07 - $11.43 | Volume 62,968 |
Average Traded $4.61 |
Rezolute, Inc. (NV) Share Price Today
As of 10 August 2026, Rezolute, Inc. (NV)'s share price is $4.67. The stock opened at $4.78, compared to its previous close of $4.70. During today's trading session, Rezolute, Inc. (NV)'s share price traded between $4.54 and $4.78, with an average price of $4.66. Over the past 52 weeks, the stock has recorded a high of $11.43 and a low of $1.07. In terms of performance, Rezolute, Inc. (NV)'s share price has risen by 45.64% over the last six months and is down 34.29% on a year-on-year basis.
Rezolute, Inc. (NV) Share Price Chart
Rezolute, Inc. (NV) Stock Fundamentals & Key Indicators
Market Cap $355.30M | PE Ratio (TTM) -4.77 | Dividend Yield N/A |
EPS (TTM) $-0.98 | Revenue (TTM) N/A | Return On Equity (TTM) -45.90% |
Profit Margin N/A | Debt to Equity 0.07 | Quarterly Earnings Growth YoY -44.78% |
Rezolute, Inc. (NV) Quarterly Profit & Loss
All figures in USD
Rezolute, Inc. (NV) Annual Profit & Loss
All figures in USD
About Rezolute, Inc. (NV)
Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. The company's lead product candidate is ersodetug, a human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It also developing RZ402, an oral plasma kallikrein inhibitor, which is in Phase 2 clinical trial for the chronic treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was incorporated in 2010 and is headquartered in Redwood City, California.
Rezolute, Inc. (NV) Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $4.60 | $4.67 | -1.16% |
Jul 2026 | $5.28 | $4.73 | -8.95% |
Jun 2026 | $3.27 | $5.20 | +56.95% |
May 2026 | $3.17 | $3.31 | +3.44% |
Apr 2026 | $3.14 | $3.20 | +5.26% |
Mar 2026 | $3.04 | $3.04 | -5.30% |
Feb 2026 | $3.28 | $3.21 | -3.75% |
Jan 2026 | $2.34 | $3.33 | +41.01% |
Dec 2025 | $9.58 | $2.37 | -75.63% |
Nov 2025 | $9.19 | $9.71 | +3.96% |
Oct 2025 | $9.47 | $9.34 | -0.74% |
Sep 2025 | $7.15 | $9.40 | +32.19% |